NCT05808855

Brief Summary

single-centre randomised prospective trial will conducted at the University Hospital of Split in Croatia. The investigators plan to enrol 100 patients, randomly assigned to suture-based wound closure (n=50) or tissue adhesive-based wound closure (n=50) with two-component skin adhesive Glubran Tiss 2®. The neurological outcomes will assessed postoperatively during the follow-up period at intervals of 2, 6, and 12 weeks respectively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 12, 2023

Completed
19 days until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

November 27, 2023

Status Verified

November 1, 2023

Enrollment Period

3 months

First QC Date

February 25, 2023

Last Update Submit

November 21, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • median nerve sensory values measured electromyographic (EMG)

    \- median nerve latency (msec)

    2 months

  • median nerve sensory values measured electromyographic (EMG)

    \- median nerve sensory conduction velocity (CV) (m/sec)

    2 months

  • median nerve sensory values measured electromyographic (EMG)

    \- median nerve sensory action potential (SAP) amplitude (mcV)

    2 months

Secondary Outcomes (4)

  • median nerve motoric values measured electromyographic (EMG)

    2 months

  • Total EMG severity classification

    2 months

  • median nerve motoric values measured electromyographic (EMG)

    2 months

  • median nerve motoric values measured electromyographic (EMG)

    2 months

Study Arms (2)

skin adhesive

EXPERIMENTAL

two-component skin adhesive Glubran Tiss 2®

Procedure: two-component skin adhesive Glubran Tiss 2®

suture-based wound closure

ACTIVE COMPARATOR

suture-based wound closure

Procedure: skin stitched with transcutaneous nylon suture

Interventions

After subcutaneous stitches with 4-0 Coated VicrylTM Plus PS-2, 3/8 (Ethicon Inc., USA); a two-component skin adhesive, 0.35 mL of Glubran Tiss 2® (GEM S.r.l., Viareggio, Italy), will be applied in the open wound. Before bandaging, subjects will rest for 20 seconds for a polymerization process.

skin adhesive

The skin is stitched with transcutaneous nylon sutures (polypropylene-polyethylene monofilament, non-absorbable surgical suture) 4-0

suture-based wound closure

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \>18 years
  • carpal tunnel syndrome
  • weakness of thumb abduction
  • with atrophy of the thenar
  • median nerve conduction impairment estimated by electromyography

You may not qualify if:

  • threatening haemorrhagic complications (patients with peroral anticoagulation and/or antithrombotic therapy)
  • previous wrist trauma or surgery on the wrist region
  • another aetiology of neuropathy
  • previous allergic reactions (with lidocaine, cyanoacrylate, formaldehyde, tapes, or adhesives)
  • personal or family history of keloids or hypertrophic scars
  • severe general illness with cachexia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Surgery Department, Plastic, Reconstructive and Aesthetic Surgery with Burn Care Division, University Hospital of Split, 21000 Croatia

Split, 21000, Croatia

Location

University Hospital of Split, 21000 Croatia

Split, Croatia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Profesor of Medicine

Study Record Dates

First Submitted

February 25, 2023

First Posted

April 12, 2023

Study Start

May 1, 2023

Primary Completion

August 1, 2023

Study Completion

October 1, 2023

Last Updated

November 27, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Data will be available on request

Locations